Stay updated on Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now indicates that enrollment is closed with a 'No longer looking for participants' note, and new help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) while the Intervention/Treatment header formatting was adjusted and the revision version updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:06:31.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5. This reflects an update to the site's revision tracking rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-06-07T01:16:03.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a new revision tag: Revision: v3.5.4. The previous revision tag Revision: v3.5.3 has been removed.
    Difference
    0.1%
    Check dated 2026-05-16T09:28:47.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a change in the site release rather than study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:23:53.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:49:13.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:08.000Z thumbnail image

Stay in the know with updates to Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in PD-1-resistant Lung Cancer Clinical Trial page.